Abu Dhabi has introduced an innovative life sciences cluster, strengthening its role as a worldwide center for biotechnology, MedTech, and digital health. Created by the Abu Dhabi Department of Economic Development, Abu Dhabi Investment Office (ADIO), and the Department of Health – Abu Dhabi, the Health, Endurance, Longevity, and Medicine (HELM) cluster aims to promote healthcare innovation, draw in international investment, and provide enduring advantages to populations worldwide.
Revealed at Abu Dhabi Global Health Week, the HELM cluster will function as a hub for the research, development, production, and marketing of advanced health and life science innovations. From AI-driven diagnostics and drug manufacturing to gene therapy and personalized medicine, the cluster is set to help global firms convert groundbreaking science into scalable and accessible, patient-centered solutions.
Abu Dhabi provides unmatched access to international markets due to its top-tier infrastructure, forward-thinking regulations, and advantageous geographic positioning. The emirate’s diverse talent pool, state-of-the-art biomanufacturing facilities, and dedication to innovation create an excellent platform for life sciences firms aiming for global expansion.
His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, said: “The launch of Abu Dhabi’s Health, Endurance, Longevity, and Medicine cluster is a bold leap forward in how the world delivers healthcare. We are not just investing in infrastructure, we’re investing in human potential, in breakthroughs that will redefine longevity, and in solutions that will reach far beyond our borders. This is where innovation meets impact.”
Built to address the increasing worldwide need for advanced healthcare, the cluster aims to confront some of the most urgent health issues globally, such as chronic and non-communicable diseases, which represent more than 70% of deaths worldwide, along with the healthcare requirements of aging populations. It is seizing growth prospects in the worldwide healthcare market, expected to hit $25.3 trillion (AED93 trillion) by 2045.
We use cookies to ensure you get the best experience on our website. Read more...